The drugmaker said in a statement that it reached a cooperation framework agreement with Sinopharm that grants the Chinese company distribution and exclusive import rights of the medicine in the China mainland market.
https://www.pharmalive.com/wp-content/uploads/2022/09/Sinopharm.jpeg400600Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-09-28 16:25:572022-09-29 10:01:09Merck agrees to allow Sinopharm to sell molnupiravir COVID drug in China
